Viewing Study NCT05081557


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-01-09 @ 2:34 PM
Study NCT ID: NCT05081557
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-14
First Post: 2021-10-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Atopic Dermatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Atopic Dermatitis View
None Atopic Eczema View
None Upadacitinib View
None RINVOQ View